RaySearch Laboratories AB (STO:RAY.B), a provider of software for radiation therapy, announced on Friday that it has secured an order worth DKK10.5m (approximately SEK15.4m) from Odense University Hospital, part of the South Denmark Region, for its RayStation treatment planning system.
Odense University Hospital's radiotherapy centre, a leader in automated treatment planning, aims to further expand automation across the entire planning process, from initial assessments to finalised treatment plans. RayStation was selected following an extensive market evaluation focused on supporting continued innovation in automation.
RayStation integrates both machine learning and traditional planning algorithms. Its upcoming version will feature a new auto-optimisation algorithm, currently under development in collaboration with Memorial Sloan Kettering Cancer Center.
Most of the revenue from the order is expected to be recognized in the first quarter of 2025. The agreement excludes a service contract and remains subject to regulatory clearance in certain markets.
(USD1.00 = DKK6.57)
Bayer launches Phase I trial of targeted alpha therapy for advanced liver cancer
Oramed Pharmaceuticals invests in and collaborates with Alpha Tau Medical
House Rx launches AI-enabled pharmacy management platform
Avacta Therapeutics reports positive Phase 1 data for lead candidate
Portage Biotech advances PORT-7 to clinical trial after positive mesothelioma preclinical results
Oncoinvent reports positive 18-month Phase 1 data for Radspherin in ovarian cancer trial
Innovent's limertinib receives Chinese regulatory approval for first-line treatment of lung cancer
Johnson & Johnson reports TAR-200 monotherapy study data in bladder cancer
InnoCare receives NMPA approval for orelabrutinib as first-line treatment for CLL/SLL in China
RaySearch Laboratories announces order from Odense University Hospital for RayStation
Guardant Health and Pfizer enter global collaboration to advance cancer therapy development
Adcendo to present clinical stage ADC data at 2025 AACR Annual Meeting